Take Action
Want to be a changemaker? Turn your passion into action and advocate with us.
Rethink is known for rethinking the status quo when it comes to breast cancer. We advocate for the most pressing needs identified by people in the breast cancer community. We work closely with people with breast cancer to ensure they are at the centre of making much-needed systems change.
#MAKEMECOUNT
You deserve to be counted. Did you know current cancer data in Canada is incomplete and fragmented, specifically around rates of recurrence of metastatic breast cancer, race, and social determinants of health?
At Rethink, we always say that we advocate for the right treatment for the right person at the right time. But if we don’t know who is actually affected by cancer, how do we know how to best treat them?
With #MakeMeCount, we are calling out the need for improved reporting on metastatic recurrence data, race-based data, and social determinants of health data within the breast cancer community.
Current Movements
#MakeMeCount
Calling out the need for improved reporting on metastatic recurrence data, race-based data, and social determinants of health data within the breast cancer community.
Break Through the Bullsh*t
Help us #BreakThroughtheBS people with cancer have to deal with when it comes to drug access.
#BitterestPill
Funding for cancer treatment shouldn’t depend on how old or young you are. For 10 years, Rethink has been advocating for equal access to take-home (oral) cancer drugs for those younger than 65 in Ontario.
Be an MBC Ally
We believe the burden of advocating for change should not be carried by those living with MBC alone. They need you to help amplify their message. That’s why we created the MBC Ally pledge.
MBC Fund
An ongoing fund and targeted initiative to fund support and research related to metastatic breast cancer.
Ongoing Drug Access Advocacy
We work with other patient groups, coalitions and cancer organizations to call for system change and more efficiencies throughout the entire process of Canadian drug approval and reimbursement process.
Advocacy Wins
MBC in the Dark
June 2018 | 10,000 allies raised their voices, leading to a change in Canada’s drug approval process around negotiation benchmarks on new breast cancer drugs.
Oncotype DX Test Funding
April 2016 | In Alberta, British Columbia and Nova Scotia, we called (and succeeded!) for greater access to tumour profiling tests, which provide valuable information oncologists and patients can use to personalize a treatment plan and make decisions around treatment options.
Deconstructing Breast Reconstruction
December 2013 | Rethink met with the Minister of Health in Ontario to address the lengthy wait-times for women who are at high risk of developing breast cancer and choose prophylactic mastectomies and we succeeded in having this addressed.
